<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">farmaec</journal-id><journal-title-group><journal-title xml:lang="en">FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology</journal-title><trans-title-group xml:lang="ru"><trans-title>ФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2070-4909</issn><issn pub-type="epub">2070-4933</issn><publisher><publisher-name>IRBIS LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17749/2070-4909/farmakoekonomika.2021.051</article-id><article-id custom-type="elpub" pub-id-type="custom">farmaec-532</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEW ARTICLES</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРНЫЕ ПУБЛИКАЦИИ</subject></subj-group></article-categories><title-group><article-title>Comparative effectiveness of simultaneous and staged operations in patients with atherosclerotic lesions of carotid and coronary arteries</article-title><trans-title-group xml:lang="ru"><trans-title>Сравнительная эффективность симультанных и этапных операций у пациентов с атеросклеротическим поражением сонных и коронарных артерий</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Исмоилова</surname><given-names>А. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Ismoilova</surname><given-names>A. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Исмоилова Азиза Бахтиёр кизи – студентка 1-го курса магистратуры по направлению «Организация и управление фармацевтическим делом»</p><p>ул. Ойбека, д. 45, Ташкент 100015, Республика Узбекистан</p></bio><bio xml:lang="en"><p>Aziza B. Ismoiliva – 1st year Master's Student in Organization and Management of Pharmaceutical Business</p><p>45 Oybek Str., Tashkent 100015, Republic of Uzbekistan</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1658-7972</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Cултанбаева</surname><given-names>Н. М.У.</given-names></name><name name-style="western" xml:lang="en"><surname>Sultanbaeva</surname><given-names>N. M.U.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Cултанбаева Наргиза Мухамед Умаровна – ассистент кафедры организации фармацевтического дела</p><p>ул. Ойбека, д. 45, Ташкент 100015, Республика Узбекистан</p></bio><bio xml:lang="en"><p>Nargiza М.U. Sultanbaeva – Assistant Professor, Chair of Pharmaceutical Business Organization</p><p>45 Oybek Str., Tashkent 100015, Republic of Uzbekistan</p></bio><email xlink:type="simple">nargiz6985@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0813-9333</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Абдурахманов</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Abdurakhmanov</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Абдурахманов Абдусалом Абдулагзамович – к.м.н., заведующий отделением кардиохирургии. WoS ResearcherID: AAR-5024-2021</p><p>ул. Нурхон, д. 2, Ташкент 100081, Республика Узбекистан</p></bio><bio xml:lang="en"><p>Abdusalom А. Abdurakhmanov – MD, PhD, Head of Department of Cardiac Surgery.  WoS ResearcherID: AAR-5024-2021</p><p>2 Nurkhon Str., Tashkent, Republic of Uzbekistan</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4106-0395</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Умарова</surname><given-names>Ш. З.</given-names></name><name name-style="western" xml:lang="en"><surname>Umarova</surname><given-names>Sh. Z.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Умарова Шахноз Зиятовна – к.фарм.н., профессор, заведующая кафедрой организации фармацевтического дела</p><p>ул. Ойбека, д. 45, Ташкент 100015, Республика Узбекистан</p></bio><bio xml:lang="en"><p>Shakhnoz Z. Umarova – PhD (Pharm.), Professor, Chief of Chair of Pharmaceutical Business Organization</p><p>45 Oybek Str., Tashkent 100015, Republic of Uzbekistan</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Джалалова</surname><given-names>Д. Х.</given-names></name><name name-style="western" xml:lang="en"><surname>Dzhalalova</surname><given-names>D. Kh.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Джалалова Дилфуза Хамидовна – заведующая научной лабораторией оценки технологии здравоохранения и фармакоэкономики</p><p>ул. Ойбека, д. 45, Ташкент 100015, Республика Узбекистан</p></bio><bio xml:lang="en"><p>Dilfuza Kh. Dzhalalova – Head of Scientific Laboratory of Health Technology Assessment and Pharmacoeconomics</p><p>45 Oybek Str., Tashkent 100015, Republic of Uzbekistan</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Джалалов</surname><given-names>С. Ч.</given-names></name><name name-style="western" xml:lang="en"><surname>Dzhalalov</surname><given-names>S. Ch.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Джалалов Санджар Чингизович – д.э.н., профессор кафедры организации фармацевтического дела</p><p>ул. Ойбека, д. 45, Ташкент 100015, Республика Узбекистан</p></bio><bio xml:lang="en"><p>Sandzhar Ch. Dzhalalov – Dr. Econ. Sc., Professor, Chair of Pharmaceutical Business Organization</p><p>45 Oybek Str., Tashkent 100015, Republic of Uzbekistan</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Ташкентский фармацевтический институт<country>Узбекистан</country></aff><aff xml:lang="en">Tashkent Pharmaceutical Institute<country>Uzbekistan</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">Республиканский научный центр экстренной медицинской помощи<country>Узбекистан</country></aff><aff xml:lang="en">Republican Scientific Center of Emergency Medical Care<country>Uzbekistan</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>27</day><month>07</month><year>2021</year></pub-date><volume>14</volume><issue>2</issue><elocation-id>263–269</elocation-id><permissions><copyright-statement>Copyright &amp;#x00A9; Ismoilova A.B., Sultanbaeva N.M., Abdurakhmanov A.A., Umarova S.Z., Dzhalalova D.K., Dzhalalov S.C., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Исмоилова А.Б., Cултанбаева Н.М., Абдурахманов А.А., Умарова Ш.З., Джалалова Д.Х., Джалалов С.Ч.</copyright-holder><copyright-holder xml:lang="en">Ismoilova A.B., Sultanbaeva N.M., Abdurakhmanov A.A., Umarova S.Z., Dzhalalova D.K., Dzhalalov S.C.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pharmacoeconomics.ru/jour/article/view/532">https://www.pharmacoeconomics.ru/jour/article/view/532</self-uri><abstract><sec><title>Objective</title><p>Objective: comparative systematic analysis of clinical trials of staged and simultaneous approaches in the surgical treatment of combined carotid and coronary stenosis based on the literature search.</p></sec><sec><title>Material and methods</title><p>Material and methods. A systematic literature search was performed in PubMed/MEDLINE, Google Scholar and Scopus using predefined acceptance criteria. To compare data of simultaneous and staged surgery cumulative indicators of heart attack, stroke and mortality, expressed as percentages and absolute numbers, were analyzed; the Mantel–Hensel formula and the χ2 method were used to assess the relative risk of major adverse cardio-cerebral events development and mortality.</p></sec><sec><title>Results</title><p>Results. The analysis included 7 studies containing one intervention (4 simultaneous and 3 stage methods). The risk of developing myocardial infarction was RR 0.13 (95% CI 0.02–0.67) for simultaneous tactics, and RR 7.79 (95% CI 1.5–40.43) for staged tactics (p˂0.005). The risk of stroke developing was RR 1.29 (95% CI 0.56–2.99) for a simultaneous approach, and RR 0.78 (95% CI 0.33–1.8) for stage approach (p˃0.05). The risk of mortality was RR 0.77 (95% CI 0.31–1.88) for simultaneous procedures, and RR 1.3 (95% CI 0.53–3.18) for staged procedures (p˃0.05).</p></sec><sec><title>Conclusion</title><p>Conclusion. Staged tactics for combined carotid and coronary stenosis may be accompanied by a significantly higher risk of myocardial infarction. There was no statistically significant difference between the groups in terms of the risk of stroke and mortality, but there was a trend towards a higher risk of stroke in the simultaneous group and a higher risk of death from all causes in the staged group.</p></sec></abstract><trans-abstract xml:lang="ru"><sec><title>Цель</title><p>Цель: сравнительный анализ клинических исследований этапного и симультанного подходов в хирургическом лечении сочетанных поражений каротидного и коронарного русла по данным литературы.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Был выполнен систематический поиск литературы в базе данных PubMed/MEDLINE, Google Scholar и Scopus с помощью предварительно определенных критериев приемлемости. Сравнивая данные симультанной хирургии с этапной хирургией, анализировали кумулятивные показатели частоты инфаркта, инсульта и летальности, выраженные в процентах и абсолютных цифрах. Для оценки относительного риска (related risk, RR) развития осложнений использовали формулу Мантеля–Хензеля и критерий χ2.</p></sec><sec><title>Результаты</title><p>Результаты. В анализ вошли 7 исследований, которые содержали одно вмешательство (4 симультанных и 3 этапных метода). Риск развития инфаркта миокарда: при симультанной тактике – RR 0,13 (95% ДИ 0,02–0,67), при этапной – RR 7,79 (95% ДИ 1,5-40,43) (р˂0,005). Риск развития инсульта: при симультанном подходе – RR 1,29 (95% ДИ 0,56–2,99), при этапном – RR 0,78 (95% ДИ 0,33–1,8) (р˃0,05). Риск летальности: при симультанных операциях – RR 0,77 (95% ДИ 0,31–1,88), при этапных – RR 1,3 (95% ДИ 0,53–3,18) (р˃0,05).</p></sec><sec><title>Заключение</title><p>Заключение. Этапная тактика при сочетанных стенозах каротидного и коронарного русла может сопровождаться достоверно более высоким риском развития инфаркта миокарда. В отношении риска развития инсульта и летальности статистически достоверной разницы между группами выявлено не было, но отмечена тенденция к более высокому риску инсульта в симультанной группе и более высокому риску смерти от всех причин в этапной группе.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>Комбинированный стеноз сонной и коронарной артерий</kwd><kwd>симультанная хирургия</kwd><kwd>этапная хирургия</kwd><kwd>аортокоронарное шунтирование</kwd><kwd>каротидная эндартерэктомия</kwd><kwd>каротидная реваскуляризация</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Combined coronary and carotid artery stenosis</kwd><kwd>simultaneous surgery</kwd><kwd>staged surgery</kwd><kwd>coronary artery bypass grafting</kwd><kwd>carotid endarterectomy</kwd><kwd>carotid revascularization</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Akins C.W., Moncure A.C., Daggett W.M., et al Safety and efficacy of concomitant carotid and coronary artery operations. Ann Thorac Surg. 1995; 60 (2): 311–7; discussion 318. https://doi.org/10.1016/0003-4975(95)00397-4.</mixed-citation><mixed-citation xml:lang="en">Akins C.W., Moncure A.C., Daggett W.M., et al Safety and efficacy of concomitant carotid and coronary artery operations. Ann Thorac Surg. 1995; 60 (2): 311–7; discussion 318. https://doi.org/10.1016/0003-4975(95)00397-4.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Darling R.C., Dylewski M., Chang B.B., et al. Combined carotid endarterectomy and coronary bypass grafting does not increase the risk of perioperative stroke. Cardiovasc Surg. 1998; 6 (5): 448–52. https://doi.org/10.1016/s0967-2109(98)00030-1.</mixed-citation><mixed-citation xml:lang="en">Darling R.C., Dylewski M., Chang B.B., et al. Combined carotid endarterectomy and coronary bypass grafting does not increase the risk of perioperative stroke. Cardiovasc Surg. 1998; 6 (5): 448–52. https://doi.org/10.1016/s0967-2109(98)00030-1.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Eagle K.A., Guyton R.A., Davidoff R., et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol. 2004; 44 (5): e213–310. https://doi.org/10.1016/j.jacc.2004.07.021.</mixed-citation><mixed-citation xml:lang="en">Eagle K.A., Guyton R.A., Davidoff R., et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol. 2004; 44 (5): e213–310. https://doi.org/10.1016/j.jacc.2004.07.021.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Brown P.P., Kugelmass A.D., Cohen D.J., et al. The frequency and cost of complications associated with coronary artery bypass grafting surgery: results from the United States Medicare program. Ann Thorac Surg. 2008; 85 (6): 1980–6. https://doi.org/10.1016/j.athoracsur.2008.01.053.</mixed-citation><mixed-citation xml:lang="en">Brown P.P., Kugelmass A.D., Cohen D.J., et al. The frequency and cost of complications associated with coronary artery bypass grafting surgery: results from the United States Medicare program. Ann Thorac Surg. 2008; 85 (6): 1980–6. https://doi.org/10.1016/j.athoracsur.2008.01.053.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Masabni K., Raza S., Blackstone E.H., et al. Does preoperative carotid stenosis screening reduce perioperative stroke in patients undergoing coronary artery bypass grafting? J Thorac Cardiovasc Surg. 2015; 149 (5): 1253–60. https://doi.org/10.1016/j.jtcvs.2015.02.003.</mixed-citation><mixed-citation xml:lang="en">Masabni K., Raza S., Blackstone E.H., et al. Does preoperative carotid stenosis screening reduce perioperative stroke in patients undergoing coronary artery bypass grafting? J Thorac Cardiovasc Surg. 2015; 149 (5): 1253–60. https://doi.org/10.1016/j.jtcvs.2015.02.003.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Hillis L.D., Smith P.K., Anderson J.L., et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011; 124 (23): 2610–42. https://doi.org/10.1161/CIR.0b013e31823b5fee.</mixed-citation><mixed-citation xml:lang="en">Hillis L.D., Smith P.K., Anderson J.L., et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011; 124 (23): 2610–42. https://doi.org/10.1161/CIR.0b013e31823b5fee.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Naylor A.R., Mehta Z., Rothwell P.M., et al. Carotid artery disease and stroke during coronary artery bypass: a critical review of the literature. Eur J Vasc Endovasc Surg. 2002; 23 (4): 283–94. https://doi.org/10.1053/ejvs.2002.1609.</mixed-citation><mixed-citation xml:lang="en">Naylor A.R., Mehta Z., Rothwell P.M., et al. Carotid artery disease and stroke during coronary artery bypass: a critical review of the literature. Eur J Vasc Endovasc Surg. 2002; 23 (4): 283–94. https://doi.org/10.1053/ejvs.2002.1609.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Nwakanma L., Poonyagariyagorn H.K., Bello R., et al. Early and late results of combined carotid endarterectomy and coronary artery bypass versus isolated coronary artery bypass. Interact Cardiovasc Thorac Surg. 2006; 5 (2): 159–65. https://doi.org/10.1510/icvts.2005.114678.</mixed-citation><mixed-citation xml:lang="en">Nwakanma L., Poonyagariyagorn H.K., Bello R., et al. Early and late results of combined carotid endarterectomy and coronary artery bypass versus isolated coronary artery bypass. Interact Cardiovasc Thorac Surg. 2006; 5 (2): 159–65. https://doi.org/10.1510/icvts.2005.114678.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Gersh B.J., Maron B.J., Bonow R.O., et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011; 124 (24): 2761–96. https://doi.org/10.1161/CIR.0b013e318223e230.</mixed-citation><mixed-citation xml:lang="en">Gersh B.J., Maron B.J., Bonow R.O., et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011; 124 (24): 2761–96. https://doi.org/10.1161/CIR.0b013e318223e230.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Aydin E., Ozen Y., Sarikaya S., Yukseltan I. Simultaneous coronary artery bypass grafting and carotid endarterectomy can be performed with low mortality rates. Cardiovasc J Afr. 2014; 25 (3): 130–3. https://doi.org/10.5830/CVJA-2014-018.</mixed-citation><mixed-citation xml:lang="en">Aydin E., Ozen Y., Sarikaya S., Yukseltan I. Simultaneous coronary artery bypass grafting and carotid endarterectomy can be performed with low mortality rates. Cardiovasc J Afr. 2014; 25 (3): 130–3. https://doi.org/10.5830/CVJA-2014-018.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Weimar C., Bilbilis K., Rekowski J., et al. Safety of simultaneous coronary artery bypass grafting and carotid endarterectomy versus isolated coronary artery bypass grafting: a randomized clinical trial. Stroke. 2017; 48 (10): 2769–75. https://doi.org/10.1161/STROKEAHA.117.017570.</mixed-citation><mixed-citation xml:lang="en">Weimar C., Bilbilis K., Rekowski J., et al. Safety of simultaneous coronary artery bypass grafting and carotid endarterectomy versus isolated coronary artery bypass grafting: a randomized clinical trial. Stroke. 2017; 48 (10): 2769–75. https://doi.org/10.1161/STROKEAHA.117.017570.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Kougias P., Kappa J.R., Sewell D.H., et al. Simultaneous carotid endarterectomy and coronary artery bypass grafting: results in specific patient groups. Ann Vasc Surg. 2007; 21 (4): 408–14. https://doi.org/10.1016/j.avsg.2006.12.007.</mixed-citation><mixed-citation xml:lang="en">Kougias P., Kappa J.R., Sewell D.H., et al. Simultaneous carotid endarterectomy and coronary artery bypass grafting: results in specific patient groups. Ann Vasc Surg. 2007; 21 (4): 408–14. https://doi.org/10.1016/j.avsg.2006.12.007.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Dönmez A.A., Adademir T., Sacli H., et al. Comparison of early outcomes with three approaches for combined coronary revascularization and carotid endarterectomy. Braz J Cardiovasc Surg. 2016; 31 (5): 365–70.</mixed-citation><mixed-citation xml:lang="en">Dönmez A.A., Adademir T., Sacli H., et al. Comparison of early outcomes with three approaches for combined coronary revascularization and carotid endarterectomy. Braz J Cardiovasc Surg. 2016; 31 (5): 365–70.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Santos A., Washington C., Rahbar R., et al. Results of staged carotid endarterectomy and coronary artery bypass graft in patients with severe carotid and coronary disease. Ann Vasc Surg. 2012; 26 (1): 102–6. https://doi.org/10.1016/j.avsg.2011.10.002.</mixed-citation><mixed-citation xml:lang="en">Santos A., Washington C., Rahbar R., et al. Results of staged carotid endarterectomy and coronary artery bypass graft in patients with severe carotid and coronary disease. Ann Vasc Surg. 2012; 26 (1): 102–6. https://doi.org/10.1016/j.avsg.2011.10.002.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Antunes P.E., Anacleto G., de Oliveira J.M., et al. Staged carotid and coronary surgery for concomitant carotid and coronary artery disease. Eur J Cardiothorac Surg. 2002; 21 (2): 181–6. https://doi.org/10.1016/s1010-7940(01)01097-1.</mixed-citation><mixed-citation xml:lang="en">Antunes P.E., Anacleto G., de Oliveira J.M., et al. Staged carotid and coronary surgery for concomitant carotid and coronary artery disease. Eur J Cardiothorac Surg. 2002; 21 (2): 181–6. https://doi.org/10.1016/s1010-7940(01)01097-1.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Meharwal Z.S., Mishra A., Trehan N. Safety and efficacy of one stage off-pump coronary artery operation and carotid endarterectomy. Ann Thorac Surg. 2002; 73 (3): 793–7. https://doi.org/10.1016/s0003-4975(01)03411-7.</mixed-citation><mixed-citation xml:lang="en">Meharwal Z.S., Mishra A., Trehan N. Safety and efficacy of one stage off-pump coronary artery operation and carotid endarterectomy. Ann Thorac Surg. 2002; 73 (3): 793–7. https://doi.org/10.1016/s0003-4975(01)03411-7.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Gopaldas R.R., Chu D., Dao T.K., et al. Staged versus synchronous carotid endarterectomy and coronary artery bypass grafting: analysis of 10-year nationwide outcomes. Ann Thorac Surg. 2011; 91 (5): 1323–9. https://doi.org/10.1016/j.athoracsur.2011.02.053.</mixed-citation><mixed-citation xml:lang="en">Gopaldas R.R., Chu D., Dao T.K., et al. Staged versus synchronous carotid endarterectomy and coronary artery bypass grafting: analysis of 10-year nationwide outcomes. Ann Thorac Surg. 2011; 91 (5): 1323–9. https://doi.org/10.1016/j.athoracsur.2011.02.053.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Tzoumas A., Giannopoulos S., Texakalidis P., et al. Synchronous versus staged carotid endarterectomy and coronary artery bypass graft for patients with concomitant severe coronary and carotid artery stenosis: a systematic review and meta-analysis. Ann Vasc Surg. 2020; 63: 427–38.e1. https://doi.org/10.1016/j.avsg.2019.09.007.</mixed-citation><mixed-citation xml:lang="en">Tzoumas A., Giannopoulos S., Texakalidis P., et al. Synchronous versus staged carotid endarterectomy and coronary artery bypass graft for patients with concomitant severe coronary and carotid artery stenosis: a systematic review and meta-analysis. Ann Vasc Surg. 2020; 63: 427–38.e1. https://doi.org/10.1016/j.avsg.2019.09.007.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
